Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Microbix Biosystems Inc
T.MBX
Alternate Symbol(s):
MBXBF
Healthcare
Biotechnology
Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency...
testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MBX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(76)
•••
wizzdumb
X
Comment by
wizzdumb
on Nov 30, 2024 9:07pm
RE:RE:RE:RE:Wonder why???
"Doing it the hard way but the right way for everybody" "It would be impossible for us not to achieve a record for the fulll12 months" "For fiscal 2025 we are looking
...more
(76)
•••
wizzdumb
X
Comment by
wizzdumb
on Nov 30, 2024 8:56pm
RE:RE:RE:Wonder why???
Beyond moving QAPs to oncology applications, if you don't know what expanding Kinlytic to additional geographic and cliinical indications means you need to do some research.
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(76)
•••
wizzdumb
X
Comment by
wizzdumb
on Nov 30, 2024 8:21pm
RE:RE:Wonder why???
Didn't call into the recent webinar due to it supposedly being for beginners, but having watched it a few times now some real buried gems in there that reinforce my faith in this company and
...more
(104)
•••
prophetoffactz
X
Comment by
prophetoffactz
on Nov 29, 2024 6:47pm
RE:Wonder why???
Lots of year-end portflio shuffling right now; including tax loss sales. Only 15 business days until Christmas week.
(29)
•••
rjc7
X
Post by
rjc7
on Nov 29, 2024 12:32pm
Wonder why???
House #91 (jones) has done all the selling today. I wonder why they'd dump at $0.31 so close to the Q and annual release numbers. Strange to me.
(4)
•••
tasman99
X
Post by
tasman99
on Nov 28, 2024 2:47pm
KOL Collaborators Present Microbix HPV Test-Control Results
WDYT?
•••
Jonathon Brown
X
Post by
Jonathon Brown
on Nov 28, 2024 5:55am
Buzz on the Bullboards: Stocks to watch in volatile times.
The TSX hit another record high on strong retail sales data and positive investor sentiment. However, the index quickly fell from grace.
read article.
(104)
•••
prophetoffactz
X
Post by
prophetoffactz
on Nov 27, 2024 3:03pm
Q4 December 19
Groome thinks "everybody will be pleased with the fourth quarter". {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v=Hg8W6A4h3LA|(fs)True
...more
(24)
•••
yielddude
X
Post by
yielddude
on Nov 26, 2024 8:26pm
Today's new investor call on adelaide youtube, fyi ...
https://www.youtube.com/watch?v=Hg8W6A4h3LA
(23)
•••
jdunlop
X
Comment by
jdunlop
on Nov 26, 2024 7:41pm
RE:RE:RE:RE:Adelaide Capital
Cameron said Dec. 19th., fourth quarter report. Expect record earnings, his words, not mine.
(76)
•••
wizzdumb
X
Comment by
wizzdumb
on Nov 22, 2024 3:46pm
RE:RE:RE:Adelaide Capital
Adelaide is doing a bunch of them for various clients, nothing to read into.
(32)
•••
Method
X
Comment by
Method
on Nov 22, 2024 2:21pm
RE:RE:RE:Adelaide Capital
I'm guessing because the tax loss selling has the stock plumbing lows so it's an attempt to help find buyers.
(29)
•••
rjc7
X
Comment by
rjc7
on Nov 22, 2024 1:51pm
RE:RE:Adelaide Capital
I'm certainly not a newbie, but any idea what the reason is for the webinar being so close to the q-4 and full year report
(76)
•••
wizzdumb
X
Comment by
wizzdumb
on Nov 22, 2024 11:34am
RE:Adelaide Capital
Just FYI this is meant for newbies to MBX and is not the 4th quarter/full year 2024 results discussion. That will be mid December likely.
(2)
•••
AngelMarti
X
Post by
AngelMarti
on Nov 21, 2024 9:00pm
Adelaide Capital
Microbix Investor Webinar Tuesday, November 26, 2024 11:00a.m. 12:00p.m. Adelaide Capital, Microbix (TSX: MBX, OTCQX: MBXBF) Investor Webinar
(76)
•••
wizzdumb
X
Comment by
wizzdumb
on Nov 21, 2024 4:39pm
RE:Imagine there’s no cervical cancer. It’s easy, if we try.
Thanks for the article, haven't heard a peep about this from the company for a while. I have been expecting more programs globally supported by MBX and updates on sales related to the ones
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing